TriKEs and BiKEs join CARs on the cancer immunotherapy highway

Unprecedented clinical success has recently been achieved in cancer immunotherapy using cytotoxic T cells armed with activating tumor-specific Chimeric Antigen Receptors (CARs). Natural killer (NK) cells, potent cytotoxic effectors, also hold potential to be effectively harnessed for immunotherapy....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hum Vaccin Immunother
Hlavní autoři: Tay, Szun Szun, Carol, Hernan, Biro, Maté
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2016
Témata:
Commentaries
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5137511/
https://ncbi.nlm.nih.gov/pubmed/27322989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1198455
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky